Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2333 (LINC02333)

Target
LINC02333
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2333 (LINC02333) is a member of the long intergenic non-coding RNA (lincRNA) class, which consists of RNA molecules longer than 200 nucleotides that are transcribed from genomic regions not overlapping protein-coding genes[1][3]. LincRNAs, including LINC02333, generally act as regulators of gene expression, functioning through mechanisms such as chromatin modification, modulation of transcriptional activity, and organization of nuclear architecture. Although only a small fraction of annotated lincRNAs have had their functions directly characterized, these RNAs are recognized as important modulators of cellular function and may play tissue-specific or disease-relevant roles. However, as of current evidence, LINC02333 itself is not a receptor, enzyme, transporter, or recognized direct therapeutic target, and no drugs are currently known to interact with it[1][3].

Other names
LINC02333long intergenic non-coding RNA 2333
02

Mechanism of action

Not applicable (no known direct drug targeting; lincRNAs act mainly at the level of gene regulation and chromatin state modulation[3])

03

Biological functions

Gene expression regulationChromatin remodelingOrganization of nuclear architectureTranscriptional regulationRNA stabilization
04

Disease associations

Potential roles in cancer and other diseases, inferred from the general functions of lincRNAs in modulating gene activity relevant to disease states[3][7]Specific disease associations for LINC02333 are not well characterized in the referenced data
05

Safety considerations

No notable safety concerns or therapeutic challenges are described, as LINC02333 is not currently considered a therapeutic drug target
06

Interacting drugs

None known
07

Biomarkers

None established for LINC02333 specifically

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2333 (LINC02333).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2333 (LINC02333).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call